Clinical Trials Browser

Phase 2 × irofulven × Breast × Clear all

NCT00003796 2013-02-11

Irofulven in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male